Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Falkai

Showing results (11-20 of 226) with videos related to

Pageof 23
Sort By:
Der Nervenarzt|April 11, 2003
[DGPPN policy paper on quality assurance and guidelines. Current status and perspectives of guideline development]W Gaebel, P Falkai,
Der Nervenarzt|June 2, 2001
[Public press commitment of the DGPPN (German Society of Psychiatry, Psychotherapy and Neurology]P Falkai, M Schmauss
Clinical Neuropharmacology|January 1, 1992
Neurodevelopmental abnormalities in schizophreniaP Falkai, B Bogerts
Fortschritte Der Neurologie-Psychiatrie|May 9, 2012
[Regenerative psychiatry: from dementia praecox to neuronal plasticity]P Falkai, A Schmitt
Fortschritte Der Neurologie-Psychiatrie|July 17, 2013
[Investigation of the influence of environmental factors in severe psychiatric diseases: epigenetics as new research tool]P Falkai, A Schmitt
International Clinical Psychopharmacology|September 2, 1999
The epidemiology of comorbidity between depression, anxiety disorders and somatic diseasesW Maier, P Falkai
MMW Fortschritte Der Medizin|August 6, 2008
[Treatment of schizophrenia: what the family doctor should know]O Gruber, P Falkai
Der Nervenarzt|February 13, 2009
[Developments in diagnosis and treatment of schizophrenic psychoses]W Maier, P Falkai
Der Nervenarzt|February 13, 2009
[From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders]O Gruber, P Falkai
Der Nervenarzt|October 31, 2006
[Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts]P Falkai, W Maier
Pageof 23

Showing results (11-20 of 226) with videos related to

Sort By:
Pageof 23
Der Nervenarzt|April 11, 2003
[DGPPN policy paper on quality assurance and guidelines. Current status and perspectives of guideline development]W Gaebel, P Falkai,
Der Nervenarzt|June 2, 2001
[Public press commitment of the DGPPN (German Society of Psychiatry, Psychotherapy and Neurology]P Falkai, M Schmauss
Clinical Neuropharmacology|January 1, 1992
Neurodevelopmental abnormalities in schizophreniaP Falkai, B Bogerts
Fortschritte Der Neurologie-Psychiatrie|May 9, 2012
[Regenerative psychiatry: from dementia praecox to neuronal plasticity]P Falkai, A Schmitt
Fortschritte Der Neurologie-Psychiatrie|July 17, 2013
[Investigation of the influence of environmental factors in severe psychiatric diseases: epigenetics as new research tool]P Falkai, A Schmitt
International Clinical Psychopharmacology|September 2, 1999
The epidemiology of comorbidity between depression, anxiety disorders and somatic diseasesW Maier, P Falkai
MMW Fortschritte Der Medizin|August 6, 2008
[Treatment of schizophrenia: what the family doctor should know]O Gruber, P Falkai
Der Nervenarzt|February 13, 2009
[Developments in diagnosis and treatment of schizophrenic psychoses]W Maier, P Falkai
Der Nervenarzt|February 13, 2009
[From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders]O Gruber, P Falkai
Der Nervenarzt|October 31, 2006
[Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts]P Falkai, W Maier
Pageof 23